Abstract
Nanomaterials are increasingly applied to develop new vaccines with new strategies. Implementation of such substances in vaccines will enhance vaccine formula immunogenicity, target delivery, and antigen stability control release. Genetically engineered virus-like particles (VLPs), structurally mimic the viruses and had been successfully used as nano vaccines. VLPs-based vaccines possess the advantage of being safe, effective, and non-infectious. Moreover, due to the optimized nano-size and repetitive structural units of the VLPs, it is suspected that those particles are highly immunogenic, even in absence of adjuvant substances. VLPs could be formulated to carry an array of heterogeneous antigens of different viruses. For all, they are considered as ideal nano vaccine model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
